Temozolomide News and Research

RSS
Chemotherapy may benefit advanced pulmonary carcinoid tumour patients

Chemotherapy may benefit advanced pulmonary carcinoid tumour patients

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Novocure: 18 physicians certified to prescribe NovoTTF Therapy in Europe and Israel

Novocure: 18 physicians certified to prescribe NovoTTF Therapy in Europe and Israel

Researchers identify new biomarker that predicts effectiveness of glioblastoma treatment

Researchers identify new biomarker that predicts effectiveness of glioblastoma treatment

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Study compares effectiveness of selumetinib, chemotherapy in patients with advanced uveal melanoma

Study compares effectiveness of selumetinib, chemotherapy in patients with advanced uveal melanoma

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Updated data from ImmunoCellular ICT-107 trial in patients with newly diagnosed GBM presented at ASCO 2014

Updated data from ImmunoCellular ICT-107 trial in patients with newly diagnosed GBM presented at ASCO 2014

AbbVie releases preliminary results from ABT-414 Phase I study in patients with recurrent or unresectable GBM

AbbVie releases preliminary results from ABT-414 Phase I study in patients with recurrent or unresectable GBM

ASCO: DelMar presents interim data from VAL-083 clinical trial in refractory GBM

ASCO: DelMar presents interim data from VAL-083 clinical trial in refractory GBM

Comprehensive genomic analysis of low-grade brain tumors sorts into three categories

Comprehensive genomic analysis of low-grade brain tumors sorts into three categories

DelMar presents pre-clinical study data that evaluates activity of VAL-083 in drug-resistant NSCLC

DelMar presents pre-clinical study data that evaluates activity of VAL-083 in drug-resistant NSCLC

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Bevacizumab offers no benefit for patients newly diagnosed with glioblastoma

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

Neuro-Oncology publishes promising phase 2 results from Agenus’ brain cancer vaccine study

Neuro-Oncology publishes promising phase 2 results from Agenus’ brain cancer vaccine study

Immunocellular Therapeutics reports positive results from ICT-107 Phase II study in glioblastoma patients

Immunocellular Therapeutics reports positive results from ICT-107 Phase II study in glioblastoma patients

Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting

Phase 1/2 clinical trial data for VAL-083 in glioblastoma is presented at 18th Annual SNO meeting

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

GW Pharmaceuticals starts Phase 1b/2a clinical trial for Recurrent Glioblastoma Multiforme

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

Scientists develop robotic systems for image-guided removal of hard-to-reach brain tumors

Scientists develop robotic systems for image-guided removal of hard-to-reach brain tumors